Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene integration to develop a new class of therapies with the aim to cure a wide range of serious and life-threatening diseases. Our novel gene correction approach, called homology-directed repair (HDR), overcomes prior limitations in specificity, efficiency, and durability of gene editing to offer broad potential for transforming human health outcomes through the delivery of one-time curative cell therapies. Our platform aims treat or cure a range of serious genetic diseases with unmet medical needs.

Biotechnology

Health Care

Life Sciences

Medical Devices

Therapeutics

Kamau Therapeutics

Matthew Porteus

Vali Barsan

Ryan S.

Liliana Nordbakk

Kirby Wallace

Kamau Therapeutics

Org chart

Similar companies